(CNN) — Last week, Tara Eacobacci had an appointment with her doctor that was devoted exclusively to the topic of health insurance. A major change to her prescription benefits meant the medication she ...
CVS Caremark, one of the three major pharmacy benefit managers (PBM) in the U.S., stopped coverage for Eli Lilly's popular weight-loss drug Zepbound, blaming drugs like it for driving up overall plan ...
Starting July 1, CVS Caremark dropped Zepbound, a GLP-1 weight loss drug, from its preferred coverage on standard plans in favor of Wegovy. Instead of Zepbound, patients are reluctantly trying Wegovy, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback